275 related articles for article (PubMed ID: 30468835)
1. The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells.
Charytoniuk T; Iłowska N; Berk K; Drygalski K; Chabowski A; Konstantynowicz-Nowicka K
Life Sci; 2019 Jan; 217():1-7. PubMed ID: 30468835
[TBL] [Abstract][Full Text] [Related]
2. Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload State.
Charytoniuk T; Harasim-Symbor E; Polak A; Drygalski K; Berk K; Chabowski A; Konstantynowicz-Nowicka K
Anticancer Agents Med Chem; 2019; 19(1):121-129. PubMed ID: 30585550
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway.
Kołakowski A; Kurzyna PF; Żywno H; Bzdęga W; Harasim-Symbor E; Chabowski A; Konstantynowicz-Nowicka K
Molecules; 2021 Jun; 26(11):. PubMed ID: 34204938
[TBL] [Abstract][Full Text] [Related]
4. The effect of enterolactone on liver lipid precursors of inflammation.
Berk K; Drygalski K; Harasim-Symbor E; Charytoniuk T; Iłowska N; Łukaszuk B; Chabowski A; Konstantynowicz-Nowicka K
Life Sci; 2019 Mar; 221():341-347. PubMed ID: 30802511
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes.
Zywno H; Bzdega W; Kolakowski A; Kurzyna P; Harasim-Symbor E; Sztolsztener K; Chabowski A; Konstantynowicz-Nowicka K
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33673122
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes.
Roszczyc-Owsiejczuk K; Zabielski P
Front Endocrinol (Lausanne); 2021; 12():635175. PubMed ID: 33815291
[TBL] [Abstract][Full Text] [Related]
7. Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD.
Sztolsztener K; Konstantynowicz-Nowicka K; Harasim-Symbor E; Chabowski A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830360
[TBL] [Abstract][Full Text] [Related]
8. New evidence for the role of ceramide in the development of hepatic insulin resistance.
Konstantynowicz-Nowicka K; Harasim E; Baranowski M; Chabowski A
PLoS One; 2015; 10(1):e0116858. PubMed ID: 25635851
[TBL] [Abstract][Full Text] [Related]
9. Antioxidants Supplementation Reduces Ceramide Synthesis Improving the Cardiac Insulin Transduction Pathway in a Rodent Model of Obesity.
Hodun K; Sztolsztener K; Chabowski A
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684414
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
[TBL] [Abstract][Full Text] [Related]
13. Enterolactone has stronger effects than enterodiol on ovarian cancer.
Liu H; Liu J; Wang S; Zeng Z; Li T; Liu Y; Mastriani E; Li QH; Bao HX; Zhou YJ; Wang X; Hu S; Gao S; Qi Y; Shen Z; Wang H; Yu M; Gao T; Johnston RN; Liu SL
J Ovarian Res; 2017 Jul; 10(1):49. PubMed ID: 28738876
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells.
Bandet CL; Tan-Chen S; Bourron O; Le Stunff H; Hajduch E
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678043
[TBL] [Abstract][Full Text] [Related]
15. How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
Bzdęga W; Kurzyna PF; Harasim-Symbor E; Hołownia A; Chabowski A; Konstantynowicz-Nowicka K
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892425
[TBL] [Abstract][Full Text] [Related]
16. Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity.
Bielawiec P; Harasim-Symbor E; Konstantynowicz-Nowicka K; Sztolsztener K; Chabowski A
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32859125
[TBL] [Abstract][Full Text] [Related]
17. PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.
Xia N; Tang Z; Wang C; Xu G; Nie X; Zhang W; Zhao Y; Wang S; Zhu X; Cui S
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):116-22. PubMed ID: 26002461
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol - A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance.
Charytoniuk T; Sztolsztener K; Harasim-Symbor E; Berk K; Chabowski A; Konstantynowicz-Nowicka K
Biomed Pharmacother; 2021 Oct; 142():112057. PubMed ID: 34435590
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipids metabolism in the salivary glands of rats with obesity and streptozotocin induced diabetes.
Garbowska M; Łukaszuk B; Mikłosz A; Wróblewski I; Kurek K; Ostrowska L; Chabowski A; Żendzian-Piotrowska M; Zalewska A
J Cell Physiol; 2017 Oct; 232(10):2766-2775. PubMed ID: 28369933
[TBL] [Abstract][Full Text] [Related]
20. Linoleic acid, α-linolenic acid and enterolactone affect lipid oxidation and expression of lipid metabolism and antioxidant-related genes in hepatic tissue of dairy cows.
Fortin É; Blouin R; Lapointe J; Petit HV; Palin MF
Br J Nutr; 2017 May; 117(9):1199-1211. PubMed ID: 28643621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
